Vimarsana
Biggest News Aggregation in the World

Page 20 - Zyme Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zyme Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zyme Communications Today - Breaking & Trending Today

Dotmatics partners with RockStep Solutions to provide an integrated solution for digitalized in vivo drug discovery - Vimarsana News

Dotmatics partners with RockStep Solutions to provide an integrated solution for digitalized in vivo drug discovery

Integration of RockStep's in vivo study management software with Dotmatics' cloud-first R&D platform will streamline experiments and workflows RockStep's Climb software will be available from

Mogrify Limited: Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer - Vimarsana News

Mogrify Limited: Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer

Mogrify Limited (Mogrify), a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming the development of ex vivo cell therapies, today announced

CN Bio Expands Service Offering to Support Oncology Drug Discovery - Vimarsana News

CN Bio Expands Service Offering to Support Oncology Drug Discovery

New Oncology Service supports unique in vitro investigations into the PK/PD relationship Harnesses CN Bio's proprietary PhysioMimix PK system Represents first implementation of intellectual

Avacta Group plc: Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership - Vimarsana News

Avacta Group plc: Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer and pre|CISION platforms, is

ERS Genomics Limited: ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement - Vimarsana News

ERS Genomics Limited: ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

License allows Cellular Engineering Technologies to develop, manufacture and commercialize next generation stem cell lines using CRISPR/Cas9 technology ERS Genomics Limited, which was formed to provide